Back to Browse Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 1

Adipose inflammation: cause or consequence of obesity-related insulin resistance

Authors Ping Jiao, Haiyan Xu

Published Date October 2008 Volume 2008:1 Pages 25—31

DOI http://dx.doi.org/10.2147/DMSO.S4180

Published 23 October 2008

Ping Jiao, Haiyan Xu

Hallett Center for Diabetes and Endocrinology, Brown Medical School, Providence, RI, USA

Abstract: Obesity constitutes a critical risk factor for the development of many life threatening diseases, particularly insulin resistance and type 2 diabetes. Adipose tissue plays an important role in regulating whole body energy homeostatsis and obesity-related insulin resistance. Inflammation has been commonly linked to insulin resistance. Recent studies demonstrated that adipose tissue is an important source for producing inflammatory molecules in the obese state, primarily due to accumulation of macrophages. Animal models deficient in key inflammatory molecules or with reduced adipose macrophage infiltration are protected from development of obesity-related insulin resistance. Repression of adipose inflammation may be a useful approach to ameliorate obesity-associated metabolic disorders.

Keywords: adipose inflammation, insulin resistance, obesity

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

The utility of bexarotene in mycosis fungoides and Sézary syndrome

Panchal MR, Scarisbrick JJ

OncoTargets and Therapy 2015, 8:367-373

Published Date: 3 February 2015

Nanostructured lipid carrier-loaded hyaluronic acid microneedles for controlled dermal delivery of a lipophilic molecule

Lee SG, Jeong JH, Lee KM, Jeong KH, Yang H, Kim M, Jung H, Lee S, Choi YW

International Journal of Nanomedicine 2014, 9:289-299

Published Date: 31 December 2013

Changes in neurophysiologic markers of visual processing following beneficial anti-VEGF treatment in macular degeneration

Vottonen P, Kaarniranta K, Pääkkönen A, Tarkka IM

Clinical Ophthalmology 2013, 7:437-442

Published Date: 27 February 2013

Polyacrylonitrile nanofibers coated with silver nanoparticles using a modified coaxial electrospinning process

Yu DG, Zhou J, Chatterton NP, Li Y, Huang J, Wang X

International Journal of Nanomedicine 2012, 7:5725-5732

Published Date: 12 November 2012

A role of cellular glutathione in the differential effects of iron oxide nanoparticles on antigen-specific T cell cytokine expression

Shen CC, Liang HJ, Wang CC, Liao MH, Jan TR

International Journal of Nanomedicine 2011, 6:2791-2798

Published Date: 8 November 2011

Hearing disability in patients with Fuchs’ endothelial corneal dystrophy: unrecognized co-pathology?

Stehouwer M, Bijlsma WR, Van der Lelij A

Clinical Ophthalmology 2011, 5:1297-1301

Published Date: 9 September 2011

Risk of “silent stroke” in patients older than 60 years: risk assessment and clinical perspectives

Jae-Sung Lim, Hyung-Min Kwon

Clinical Interventions in Aging 2010, 5:239-251

Published Date: 2 September 2010

Clinical characteristics and long-term response to mood stabilizers in patients with bipolar disorder and different age at onset

Bernardo Dell’Osso, Massimiliano Buoli, Riccardo Riundi, Nazario D’Urso, et al.

Neuropsychiatric Disease and Treatment 2009, 5:399-404

Published Date: 14 July 2009